Literature DB >> 20018842

Nuclear factor (NF)-kappaB-dependent thyroid hormone receptor beta1 expression controls dendritic cell function via Akt signaling.

Iván D Mascanfroni1, María del Mar Montesinos, Vanina A Alamino, Sebastián Susperreguy, Juan P Nicola, Juan M Ilarregui, Ana M Masini-Repiso, Gabriel A Rabinovich, Claudia G Pellizas.   

Abstract

Despite considerable progress in our understanding of the interplay between immune and endocrine systems, the role of thyroid hormones and their receptors in the control of adaptive immunity is still uncertain. Here, we investigated the role of thyroid hormone receptor (TR) beta(1) signaling in modulating dendritic cell (DC) physiology and the intracellular mechanisms underlying these immunoregulatory effects. Exposure of DCs to triiodothyronine (T(3)) resulted in a rapid and sustained increase in Akt phosphorylation independently of phosphatidylinositol 3-kinase activation, which was essential for supporting T(3)-induced DC maturation and interleukin (IL)-12 production. This effect was dependent on intact TR beta(1) signaling as small interfering RNA-mediated silencing of TR beta(1) expression prevented T(3)-induced DC maturation and IL-12 secretion as well as Akt activation and I kappaB-epsilon degradation. In turn, T(3) up-regulated TR beta(1) expression through mechanisms involving NF-kappaB, suggesting an autocrine regulatory loop to control hormone-dependent TR beta(1) signaling. These findings were confirmed by chromatin immunoprecipitation analysis, which disclosed a new functional NF-kappaB consensus site in the promoter region of the TRB1 gene. Thus, a T(3)-induced NF-kappaB-dependent mechanism controls TR beta(1) expression, which in turn signals DCs to promote maturation and function via an Akt-dependent but PI3K-independent pathway. These results underscore a novel unrecognized target that regulates DC maturation and function with critical implications in immunopathology at the cross-roads of the immune-endocrine circuits.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20018842      PMCID: PMC2843207          DOI: 10.1074/jbc.M109.071241

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  In vivo cross-linking and immunoprecipitation for studying dynamic Protein:DNA associations in a chromatin environment.

Authors:  M H Kuo; C D Allis
Journal:  Methods       Date:  1999-11       Impact factor: 3.608

Review 2.  Immune and endocrine interactions.

Authors:  Lidy Verburg-van Kemenade; Carl Schreck
Journal:  Gen Comp Endocrinol       Date:  2007 Jun-Jul       Impact factor: 2.822

3.  Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10.

Authors:  Juan M Ilarregui; Diego O Croci; Germán A Bianco; Marta A Toscano; Mariana Salatino; Mónica E Vermeulen; Jorge R Geffner; Gabriel A Rabinovich
Journal:  Nat Immunol       Date:  2009-08-09       Impact factor: 25.606

4.  Control of dendritic cell maturation and function by triiodothyronine.

Authors:  Ivan Mascanfroni; María del Mar Montesinos; Sebastián Susperreguy; Laura Cervi; Juan M Ilarregui; Vanesa D Ramseyer; Ana M Masini-Repiso; Héctor M Targovnik; Gabriel A Rabinovich; Claudia G Pellizas
Journal:  FASEB J       Date:  2007-11-08       Impact factor: 5.191

Review 5.  Mechanisms of nongenomic actions of thyroid hormone.

Authors:  Paul J Davis; Jack L Leonard; Faith B Davis
Journal:  Front Neuroendocrinol       Date:  2007-10-05       Impact factor: 8.606

6.  Leptin induces CD40 expression through the activation of Akt in murine dendritic cells.

Authors:  Queenie Lai Kwan Lam; Bo-Jian Zheng; Dong-Yan Jin; Xuetao Cao; Liwei Lu
Journal:  J Biol Chem       Date:  2007-07-27       Impact factor: 5.157

Review 7.  Interactions of tumor cells with dendritic cells: balancing immunity and tolerance.

Authors:  M V Dhodapkar; K M Dhodapkar; A K Palucka
Journal:  Cell Death Differ       Date:  2007-10-19       Impact factor: 15.828

8.  T3 increases Na-K-ATPase activity via a MAPK/ERK1/2-dependent pathway in rat adult alveolar epithelial cells.

Authors:  Jianxun Lei; Cary N Mariash; Maneesh Bhargava; Elizabeth V Wattenberg; David H Ingbar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-01-25       Impact factor: 5.464

9.  Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation.

Authors:  Kun-yong Kim; Ahmi Baek; Ji-Eun Hwang; Yeon A Choi; Joon Jeong; Myeong-Sok Lee; Dea Ho Cho; Jong-Seok Lim; Keun Il Kim; Young Yang
Journal:  Cancer Res       Date:  2009-04-14       Impact factor: 12.701

Review 10.  Promotion by thyroid hormone of cytoplasm-to-nucleus shuttling of thyroid hormone receptors.

Authors:  Paul J Davis; Faith B Davis; Hung-Yun Lin
Journal:  Steroids       Date:  2008-01-16       Impact factor: 2.668

View more
  15 in total

Review 1.  Kinase AKT controls innate immune cell development and function.

Authors:  Yan Zhang; Xiao Wang; Hui Yang; Huanrong Liu; Yun Lu; Limei Han; Guangwei Liu
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

Review 2.  Photoperiodic time measurement and seasonal immunological plasticity.

Authors:  Tyler J Stevenson; Brian J Prendergast
Journal:  Front Neuroendocrinol       Date:  2014-10-27       Impact factor: 8.606

3.  AEG-1 regulates retinoid X receptor and inhibits retinoid signaling.

Authors:  Jyoti Srivastava; Chadia L Robertson; Devaraja Rajasekaran; Rachel Gredler; Ayesha Siddiq; Luni Emdad; Nitai D Mukhopadhyay; Shobha Ghosh; Phillip B Hylemon; Gregorio Gil; Khalid Shah; Deepak Bhere; Mark A Subler; Jolene J Windle; Paul B Fisher; Devanand Sarkar
Journal:  Cancer Res       Date:  2014-08-15       Impact factor: 12.701

4.  Activated apoptotic cells induce dendritic cell maturation via engagement of Toll-like receptor 4 (TLR4), dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN), and β2 integrins.

Authors:  Sushil Kumar Pathak; Annette E Sköld; Venkatramanan Mohanram; Catrine Persson; Ulrika Johansson; Anna-Lena Spetz
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

Review 5.  Neuroendocrine control of photoperiodic changes in immune function.

Authors:  Zachary M Weil; Jeremy C Borniger; Yasmine M Cisse; Bachir A Abi Salloum; Randy J Nelson
Journal:  Front Neuroendocrinol       Date:  2014-10-18       Impact factor: 8.606

6.  Antitumor Responses Stimulated by Dendritic Cells Are Improved by Triiodothyronine Binding to the Thyroid Hormone Receptor β.

Authors:  Vanina A Alamino; Iván D Mascanfroni; María M Montesinos; Nicolás Gigena; Ana C Donadio; Ada G Blidner; Sonia I Milotich; Sheue-Yann Cheng; Ana M Masini-Repiso; Gabriel A Rabinovich; Claudia G Pellizas
Journal:  Cancer Res       Date:  2015-02-11       Impact factor: 12.701

7.  NF-kappaB p65 subunit mediates lipopolysaccharide-induced Na(+)/I(-) symporter gene expression by involving functional interaction with the paired domain transcription factor Pax8.

Authors:  Juan Pablo Nicola; Magalí Nazar; Iván Darío Mascanfroni; Claudia Gabriela Pellizas; Ana María Masini-Repiso
Journal:  Mol Endocrinol       Date:  2010-07-28

8.  The thyroid hormone triiodothyronine reinvigorates dendritic cells and potentiates anti-tumor immunity.

Authors:  V A Alamino; M M Montesinos; G A Rabinovich; C G Pellizas
Journal:  Oncoimmunology       Date:  2015-07-01       Impact factor: 8.110

9.  Cell-autonomous iodothyronine deiodinase expression mediates seasonal plasticity in immune function.

Authors:  Tyler J Stevenson; Kenneth G Onishi; Sean P Bradley; Brian J Prendergast
Journal:  Brain Behav Immun       Date:  2013-10-19       Impact factor: 7.217

10.  Distribution of subpopulations of dendritic cells in peripheral blood of patients treated with exogenous thyrotropin.

Authors:  Mariusz Stasiołek; Zbigniew Adamczewski; Bartosz Puła; Kinga Krawczyk-Rusiecka; Arkadiusz Zygmunt; Magdalena Borowiecka; Piotr Dzięgiel; Andrzej Lewiński
Journal:  Thyroid Res       Date:  2012-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.